TAM Plasticity under androgen deprivation therapy and PARP inhibition in prostate cancer: a multi-omics perspective
Androgen deprivation therapy (ADT) and next-generation androgen receptor pathway inhibitors (ARPI) are increasingly combined with PARP inhibitors (PARPi) in metastatic prostate cancer (mPCa). These treatments have improved outcomes, yet responses remai…